According to the unofficial information being at disposal of JSC Grindeks about the tender of the block of shares in the polish pharmaceutical company Jelfa, there were four bidders, including JSC Grindeks, taking part at the second stage of the tender. The biggest sum offered for the purchase of the block of the shares of PF Jelfa S.A. was offered by the Lithuanian pharmaceutical company Sanitas.

On the 5 October this year Polish Industrial Development Agency (IDA) invited JSC Grindeks to submit its second price offer to the tender of acquisition of 47,83% share capital of the pharmaceutical company Jelfa S.A. JSC Grindeks applied for the tender, this time submitting price offer PLN 73 per share.

Valdis Jakobsons, Chairman of the Management Board, giving comments on the offer price per share, pointed out: “Already for a year we are having a good cooperation with this company in contract manufacture of the injection forms of our originator product Mildronate. During this year we get to know well company Jelfa and we have developed our standpoint about the value of this enterprise and what is the price we are ready to pay for it.”